Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Vaccine ; 31(44): 5062-6, 2013 Oct 17.
Artigo em Inglês | MEDLINE | ID: mdl-24021308

RESUMO

Pseudomonas aeruginosa is an important opportunistic human pathogen that causes severe infections in immunocompromised patients and also in cystic fibrosis patients. The aim of this work was to study if a bovine serum albumin nanoparticles with entrapped antigens extracted from P. aeruginosa would be able to protect mice from nasal infection by this pathogen. Mice were immunized via the subcutaneous route using P. aeruginosa antigens, empty nanoparticles or nanoparticles with entrapped P. aeruginosa antigens on days 0, 7 and 14. The total IgG antibody production and specific IgG1 and IgG2a titer were measured by ELISA. Immunized mice were challenged with live P. aeruginosa and their lungs were collected for histopathology studies. Our data showed that NPPa-vaccinated mice presented a high anti-Pseudomonas IgG1 and a low IgG2a antibody titles and decreased inflammatory signs, with significant reduction in intensity and concentration of inflammatory cells, lower hemorrhagic, edema and hyperemia signs in the lungs of challenge mice with live P. aeruginosa if compared to the other groups. Therefore, this formulation is able to induce a functional response in an animal model of infection and thereby is a promising platform for P. aeruginosa vaccines.


Assuntos
Antígenos de Bactérias/imunologia , Vacinas Bacterianas/imunologia , Pulmão/patologia , Nanopartículas , Infecções por Pseudomonas/prevenção & controle , Soroalbumina Bovina/administração & dosagem , Animais , Anticorpos Antibacterianos/sangue , Imunoglobulina G/sangue , Inflamação/microbiologia , Inflamação/patologia , Pulmão/microbiologia , Masculino , Camundongos , Infecções por Pseudomonas/imunologia
2.
ASN Neuro ; 2(5): e00048, 2010 Nov 19.
Artigo em Inglês | MEDLINE | ID: mdl-21113232

RESUMO

We have previously demonstrated that aTf (apotransferrin) accelerates maturation of OLs (oligodendrocytes) in vitro as well as in vivo. The purpose of this study is to determine whether aTf plays a functional role in a model of H/I (hypoxia/ischaemia) in the neonatal brain. Twenty-four hours after H/I insult, neonatal rats were intracranially injected with aTf and the effects of this treatment were evaluated in the CC (corpus callosum) as well as the SVZ (subventricular zone) at different time points. Similar to previous studies, the H/I event produced severe demyelination in the CC. Demyelination was accompanied by microglial activation, astrogliosis and iron deposition. Ferritin levels increased together with lipid peroxidation and apoptotic cell death. Histological examination after the H/I event in brain tissue of aTf-treated animals (H/I aTF) revealed a great number of mature OLs repopulating the CC compared with saline-treated animals (H/I S). ApoTf treatment induced a gradual increase in MBP (myelin basic protein) and myelin lipid staining in the CC reaching normal levels after 15 days. Furthermore, significant increase in the number of OPCs (oligodendroglial progenitor cells) was found in the SVZ of aTf-treated brains compared with H/I S. Specifically, there was a rise in cells positive for OPC markers, i.e. PDGFRα and SHH(+) cells, with a decrease in cleaved-caspase-3(+) cells compared with H/I S. Additionally, neurospheres from aTf-treated rats were bigger in size and produced more O4/MBP(+) cells. Our findings indicate a role for aTf as a potential inducer of OLs in neonatal rat brain in acute demyelination caused by H/I and a contribution to the differentiation/maturation of OLs and survival/migration of SVZ progenitors after demyelination in vivo.


Assuntos
Apoproteínas/fisiologia , Hipóxia-Isquemia Encefálica/patologia , Hipóxia-Isquemia Encefálica/prevenção & controle , Bainha de Mielina/metabolismo , Bainha de Mielina/patologia , Recuperação de Função Fisiológica/fisiologia , Transferrina/fisiologia , Animais , Animais Recém-Nascidos , Apoproteínas/uso terapêutico , Células Cultivadas , Corpo Caloso/patologia , Corpo Caloso/fisiologia , Feminino , Humanos , Hipóxia-Isquemia Encefálica/fisiopatologia , Masculino , Bainha de Mielina/fisiologia , Células-Tronco Neurais/patologia , Células-Tronco Neurais/fisiologia , Oligodendroglia/patologia , Oligodendroglia/fisiologia , Ratos , Ratos Wistar , Transferrina/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA